Back
Halozyme Therapeutics Stock Predictions
AI Marketing Is Moving Fast–Don't Miss Your Window!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Buy
77
HALO
Halozyme Therapeutics
Last Price:
$61.95
Seasonality Move:
3.37%
7 Day Trial
ALL ACCESS PASS
$
7
Marketing's AI Disruption Is Now Secure Your Stake Today!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.Halozyme Therapeutics Stock Forecast
-
Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 27.6% based on the past 21 years of stock performance.
-
Halozyme Therapeutics has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Halozyme Therapeutics Stock Undervalued?The current Halozyme Therapeutics [HALO] share price is $63.81. The Score for HALO is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 27.6% based on the past 21 years of stock performance.
Halozyme Therapeutics Stock Rating
Buy
77
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics overpriced?
-
Halozyme Therapeutics has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Halozyme Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
66.00
52-Week Low:
37.73
Prediction Charts
Market Cap:
7.9B
Price in USD:
63.81
Volume:
1.6M
Beta:
1.44
Technical Analysis
SMA50:
59.07
SMA100:
54.79
SMA200:
55.14
52-Wk Change:
56.86%
Stock Predictions
-
Is Halozyme Therapeutics stock public?Yes, Halozyme Therapeutics is a publicly traded company.
-
What is the Halozyme Therapeutics stock quote today?The Halozyme Therapeutics stock price is 63.81 USD today.
-
How to buy Halozyme Therapeutics stock online?You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-12 | 61.47 | 60.89 | 62.03 | 60.38 |
| Mar-13 | 60.77 | 61.06 | 61.48 | 60.44 |
| Mar-14 | 61.22 | 62.25 | 62.72 | 61.11 |
| Mar-17 | 62.46 | 62.95 | 63.39 | 60.92 |
| Mar-18 | 62.62 | 62.54 | 63.18 | 62.13 |
| Mar-19 | 62.59 | 64.30 | 64.55 | 62.52 |
| Mar-20 | 63.91 | 64.32 | 64.94 | 63.88 |
| Mar-21 | 64.32 | 65.19 | 65.21 | 63.50 |
| Mar-24 | 65.69 | 64.02 | 66.00 | 62.85 |
| Mar-25 | 63.90 | 64.84 | 65.03 | 63.51 |
| Mar-26 | 65.03 | 63.82 | 65.03 | 63.21 |
| Mar-27 | 63.79 | 64.48 | 64.61 | 63.38 |
| Mar-28 | 64.35 | 63.84 | 64.35 | 62.72 |
| Mar-31 | 63.39 | 63.81 | 64.07 | 62.60 |
Halozyme Therapeutics Earnings
Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics Forecast Revenue Growth
Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.77 per share, and an increase next year of $1.51 per share.
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.